United BioSource (UBC) Acquires Examoto, LLC

United BioSource (UBC) Acquires Evidinno Outcomes Research

January 5, 2026

Healthcare Services

United BioSource LLC (UBC) has acquired Vancouver-based Evidinno Outcomes Research Inc., adding real-world evidence (RWE), epidemiology, evidence synthesis and HEOR capabilities to UBC's evidence-generation platform. Evidinno will operate as a wholly owned subsidiary of UBC; Fairmount Partners served as exclusive financial advisor to Evidinno.

United BioSource (UBC) Acquires MarketShare Movers (MSM)

March 9, 2022

Healthcare Services

United BioSource LLC (UBC) has acquired MarketShare Movers (MSM), a data-driven prescription drug benefit and patient affordability company. The acquisition expands UBC's patient access and affordability capabilities by adding MSM's co-pay program execution, pharmacy adjudication, and proprietary analytics to UBC's patient access and commercialization services.

Normec Enters U.S., Acquires MS Bio, M.J. Reider and NorthEast BioLab

August 6, 2025

Professional Services

Normec, the Astorg-backed European testing, inspection, certification and compliance (TICC) platform, has entered the United States by acquiring three specialized laboratories: MS Bio (Champaign, IL), M.J. Reider (Reading/near Philadelphia, PA) and NorthEast BioLab (Hamden, CT). The deals expand Normec’s capabilities across food/supplement testing, water/environmental analysis and bioanalytical/CRO services, more than doubling its addressable market in North America.

Symeres Acquires Exemplify BioPharma

October 25, 2022

Pharmaceuticals

Symeres, a Netherlands-headquartered transatlantic CRO/CDMO majority‑owned by Keensight Capital, has acquired Exemplify BioPharma, a Cranbury, New Jersey-based CMC-focused CRO. The deal strengthens Symeres' capabilities in process and analytical chemistry and formulation development and further expands its strategic foothold in the United States.

iuvo BioScience Acquires Promedica International

January 18, 2024

Healthcare Services

iuvo BioScience, a Rochester-based specialty preclinical and clinical services provider backed by Ampersand Capital Partners, has acquired Promedica International, an ophthalmology-focused clinical CRO headquartered in Costa Mesa, California. The deal combines iuvo's laboratory and consulting capabilities with Promedica's ophthalmic clinical trial expertise to create an integrated end-to-end ophthalmology clinical research offering.

StemBioSys Acquires Majority Stake in Cartox

January 8, 2020

Biotechnology

San Antonio-based StemBioSys acquired a majority stake in Ann Arbor startup Cartox, obtaining control with plans to purchase the remaining equity subject to milestones. The deal brings Cartox's cardiotoxicity imaging and assay capabilities together with StemBioSys's CELLvo extracellular matrix technology to accelerate commercial development of pre-clinical cardiac safety and efficacy screening solutions.